Machine learning identifies prognostic subtypes of the tumor microenvironment in non-small cell lung cancer

Howlader, N. etc SEER Cancer Statistics Review, 1975-2017 Volume 4 (National Cancer Institute, 2020).

Google Academic

Liao, G. etc Prognostic Role of Soluble Programmed Cell Death Ligand 1 in Non-Small Cell Lung Cancer: A Systematic Review and Meta-analysis. Front desk. Oncol. 11774131 (2021).

Article CAS PubMed PubMed Central Google Scholar

Tubin, S., Khan, M. K., Gupta, S., Jeremic, B. Biology of NSCLC: Interactions between cancer cells, radiation, and the tumor immune microenvironment. cancer 13775 (2021).

Article CAS PubMed PubMed Central Google Scholar

Barta, JA, Powell, CA, Wisnivesky, JP Global epidemiology of lung cancer. Anne Grove Health 852419 (2019).

Google Academic

Howlader, N. etc Impact of advances in lung cancer treatment on population mortality. N. Engl. J. Med. 383640–649 (2020).

Article CAS PubMed PubMed Central Google Scholar

Siegel, RL, Miller, KD, Jemal, A. Cancer Statistics, 2019. CA Cancer J. Clin. 697–34 (2019).

Article PubMed Google Scholar

Varela, G. & Thomas, P. A. Surgical management of advanced non-small cell lung cancer. J. Solak. Dis. 6S217 (2014).

PubMed PubMed Central Google Scholar

Miller, K.D. etc Cancer treatment and survival statistics 2019. CA Cancer J. Clin. 69363–385 (2019).

Article PubMed Google Scholar

Goldstraw, P. etc Non-small cell lung cancer. Lancet 3781727–1740 (2011).

Article Google Scholar

Tan, C. etc Development of an immunopathology-based radiomics model for non-small cell lung cancer. Scientific Representative 81–9 (2018).

Advertisement Google Scholar

Azuma Isao etc Association between PD-L1 overexpression and activating EGFR mutations in surgically resected non-small cell lung cancer. Ann.Oncol. twenty five1935-1940 (2014).

Article CAS PubMed Google Scholar

Meyers, D., Bryan, P., Banerji, S. & Morris, D. Targeting the PD-1/PD-L1 axis in the treatment of non-small cell lung cancer. Current Oncology twenty five324–334 (2018).

Article Google Scholar

Gallon, E.B. etc Pembrolizumab for the treatment of non-small cell lung cancer. N. Engl. J. Med. 3722018–2028 (2015).

Article PubMed Google Scholar

Brahma JR etc Safety and activity of anti-PD-L1 antibodies in patients with advanced cancer. N. Engl. J. Med. 3662455–2465 (2012).

Article CAS PubMed PubMed Central Google Scholar

Glatzel Pluczynska, N. etc SATB1 levels correlate with Ki-67 expression and are a positive prognostic factor in non-small cell lung cancer. Anticancer Drug Research 38723–736 (2018).

CAS PubMed Google Scholar

Pavelczyk, K. etc The role of PD-L1 expression in non-small cell lung cancer and its prognostic significance according to clinicopathological factors and diagnostic markers. International Journal of Molecular Science 20824 (2019).

Article CAS PubMed PubMed Central Google Scholar

Masayuki Shimoji etc Clinical and pathological characteristics of programmed cell death ligand 1 (PD-L1)-expressing lung cancer. lung cancer 9869–75 (2016).

Article PubMed Google Scholar

Sun, J.-M. etc Prognostic significance of PD-L1 in patients with non-small cell lung cancer: a large cohort study of surgically resected cases. J. Thoracic Oncology 111003–1011 (2016).

Article CAS PubMed Google Scholar

Zhou, C. etc PD-L1 expression as a poor prognostic factor in patients with nonsquamous non-small cell lung cancer. Oncotarget 858457 (2017).

Article PubMed PubMed Central Google Scholar

Cooper, Washington etc PD-L1 expression is a favorable prognostic factor in early stage non-small cell lung cancer. lung cancer 89181–188 (2015).

Article PubMed Google Scholar

Teng, MW, Ngiow, SF, Ribas, A. & Smyth, MJ Classification of cancer based on T cell infiltration and PD-L1. Cancer Research 752139–2145 (2015).

Article CAS PubMed PubMed Central Google Scholar

Guo, W., Ji, Y., Catenacci, D. V. Subgroup cluster-based Bayesian adaptive design for precision medicine. Biometric authentication 73367–377 (2017).

Article MathSciNet PubMed Google Scholar

Fisher, R., Pusztai, L., Swanton, C. Cancer heterogeneity: implications for targeted therapy. Br. J. Cancer 108479–485 (2013).

Article CAS PubMed PubMed Central Google Scholar

Dagogo-Jack, I. & Shaw, A. T. Tumor heterogeneity and resistance to cancer therapy. Journal of the National Society of Clinical Oncology 1581–94 (2018).

Article CAS PubMed Google Scholar

Yu, D. etc Machine learning prediction of poor outcome in patients with non-traumatic subarachnoid hemorrhage. Ann. Clin. Transl. Neurol. 72178–2185 (2020).

Article PubMed PubMed Central Google Scholar

Luo, W. etc Guidelines for developing and reporting machine learning predictive models in biomedical research: an interdisciplinary perspective. J. Med. Internet Research 18e323 (2016).

Article PubMed PubMed Central Google Scholar

Sun, W., Jiang, M., Dang, J., Chang, P. & Yin, F.-F. Effect of machine learning methods on prediction of NSCLC overall survival based on radiomics analysis. Radiation Oncology 131–8 (2018).

Article Google Scholar

Ou, F.-S., Michiels, S., Shyr, Y., Adjei, AA & Oberg, AL Biomarker discovery and validation: statistical considerations. J. Thoracic Oncology 16537–545 (2021).

Article CAS PubMed PubMed Central Google Scholar

Heiden, B.T. etc Analysis of delayed surgical treatment and oncologic outcomes in clinical stage I non-small cell lung cancer. JAMA Network Open Foure2111613–e2111613 (2021).

Article PubMed PubMed Central Google Scholar

Andersen, P. K. & Gill, R. D. Cox regression models for counting processes: a large sample study. Ann. Stat. Ten1100–1120 (1982).

Article MathSciNet Google Scholar

Kalbfleisch, J.D. & Prentiss, R.L. Statistical analysis of failure time data (Wiley, 2011).

Google Academic

Binder, H., Allignol, A., Schumacher, M., Beyersmann, J. Boosting for high-dimensional time-to-event data with competing risks. Bioinformatics twenty five890–896 (2009).

Article CAS PubMed Google Scholar

Ishwaran, H., Kogalur, U.B., Blackstone, E.H. & Lauer, M.S. Random survival forests. Ann. Appl. Stat. 2841–860 (2008).

Article MathSciNet Google Scholar

Yeager, B.C. etc Diagonal random survival forest. Ann. Appl. Stat. 131847–1883 ​​(2019).

Article MathSciNet PubMed PubMed Central Google Scholar

Harrell, FE, Califf, RM, Pryor, DB, Lee, KL, Rosati, RA Assessing medical testing yield. Jammer 2472543–2546 (1982).

Article PubMed Google Scholar

Lang, M. etc mlr3: A modern object-oriented machine learning framework for R. J. Open Source Software Four1903 (2019).

Article Advertisement Google Scholar

Stephoven, DJ & Stephoven, MDJ Package 'missForest'. R package version 1 (2013).